39th ECNP Congress: Program & Speakers
52 major sessions across 4 days with 149 confirmed speakers — the substantive program for 39th ECNP Congress, October 10–13, 2026 in Munich, Germany. Curated from the official program; excludes posters, exhibits, and social events.
Featured speakers: Kay Tye · Ian Maze · Oliver Howes · Frank Winkler · Lukoye Atwoli · Lucia Valmaggia · Argyris Stringaris · Christian Otte · Heidi Taipale · Blanca Bolea-Alamanac · Henk Oster · Gabriel Tofani · and 137 more below
No sessions match those filters. — or browse the full official program.
October 10, 2026
- KeynoteKL01 – Welcome, ECNP Awards Ceremony and Keynote Lecture 'Neural mechanisms of social homeostasis'
Opening keynote by Salk Institute neuroscientist Kay Tye on how neural circuits maintain social homeostasis and encode emotional valence.
- SymposiumS01 – Clinical trials across psychiatric disorders: the good, bad and the ugly
Argyris Stringaris · Christian Otte · Heidi Taipale · Blanca Bolea-Alamanac
Critical look at psychiatric trial design, generalizability, and digital therapeutics, including who gets excluded from RCTs.
- SymposiumS02 – Rhythms and blues – unravelling circadian-stress interactions in mental health
Henk Oster · Gabriel Tofani · Robert Thompson · Nicholas Meyer
How circadian clocks, stress systems, and the gut microbiome interact to shape mental health and sleep.
Inflammation & ImmunopsychiatryNeuroscience & MechanismsSleep & Insomnia
- SymposiumS03 – Breaking Hot Topic Symposium – showcasing the timeliest science – Altered immune function in psychiatric disorders and their treatment
Boris B. Quednow · Sinead King · Jenny Borkent · Anthony Vernon · Cynthia Fu
Late-breaking findings on immune dysfunction in psychiatry, including the MEMOCYCLINE trial, microbiome-guided treatment, and immune-ageing phenotypes of depression.
DepressionInflammation & ImmunopsychiatryDrug Pipeline & Clinical Trials
- LectureE01 – Targeting the immune pathogenesis for the development of novel diagnostics and therapeutics of affective and non-affective psychosis
Paolo Enrico · Rachel Upthegrove
Educational update on immune-molecular patient stratification and multimodal inflammation measures in early psychosis.
Inflammation & ImmunopsychiatryPharmacogenomics & Precision PsychiatrySchizophrenia & Psychosis
October 11, 2026
- PlenaryPL01 – Protein monoaminylation in the brain: novel mechanisms of neural development, plasticity, and disease
Plenary on non-canonical roles of serotonin and other monoamines as direct protein modifications influencing gene expression and plasticity.
- PlenaryPL02 – ECNP Neuropsychopharmacology Award Lecture – How will we get novel medicines in psychiatry? Lessons from schizophrenia
Award lecture drawing lessons from schizophrenia drug development for the broader pipeline of novel psychiatric medicines.
- SymposiumS04 – Updates on bipolar disorder research: advancing translation into clinical practice
Galila Agam · Olav B Smeland · Frank Bellivier · Caterina del Mar Bonnin Roig
Sex differences, genomics, lithium-response prediction (R-LiNK), and cognitive resilience in bipolar disorder.
Bipolar DisorderLithium & Mood StabilizersPharmacogenomics & Precision Psychiatry
- SymposiumS05 – Biomarker-based prediction and stratification in ADHD – where do we stand?
Cristine Marie Yde Ohki · Carmen Schiweck · Barbara Franke · Marta Ribasés
Microbiota metabolites, inflammation, epigenetics, and polygenic risk as candidate stratification biomarkers in ADHD.
ADHDInflammation & ImmunopsychiatryPharmacogenomics & Precision Psychiatry
- SymposiumS06 – Retinal imaging in mental disorders: a novel lens on central nervous system dysfunction
Steven Silverstein · Philipp Homan · Kathrin Nickel
Retinal neural and microvascular changes as accessible windows on CNS dysfunction in psychosis and autism.
Autism & Neurodevelopmental DisordersNeuroscience & MechanismsSchizophrenia & Psychosis
- SymposiumS07 – Engineering mental health: targeted therapies to restore brain and brain-barrier function
Marianne Mueller · Stefan Liebner · Matthew Campbell · Karen Aboody
Blood-brain barrier biology as a therapeutic target, plus stem-cell-derived vesicles and focused ultrasound approaches.
- SymposiumS08 – Speech, digital phenotyping, and artificial intelligence in understanding and predicting trajectories and upcoming episodes in affective disorders
Dominic Oliver · Vera Ludwig · Srinivasan Vairavan · Maria Faurholt-Jepsen
NLP on health records, smartphone-based phenotyping, and machine learning to predict mood episodes and classify affective disorders.
- SymposiumS09 – Beyond borders: exploring the biological correlates of borderline personality disorder and implications for treatment
Jose Luis Carrasco · Elisabetta Maffioletti · Mariana Mendoza Alvarez · Christian Schmahl
Psychobiological models, peripheral molecular markers, REM sleep, and neuroimaging-treatment interactions in borderline personality disorder.
- LectureE02 – EPA Session – Improving psychiatric care in clinical practice: modern ways for treatment delivery
Martina Rojnic-Kuzman · Umberto Volpe
Joint EPA educational session on prevention, early intervention, and implementing digital psychiatry in routine care.
- LectureE03 – Advances in Tourette syndrome research
Tammy Hedderly · Juan Carlos Baldermann
Update on childhood diagnosis and the neuropathophysiology and treatment of Tourette syndrome.
Autism & Neurodevelopmental DisordersChild & AdolescentNeuroscience & Mechanisms
- SymposiumMS01 – Mini Symposium – Amyloid- and tau-PET biomarkers in late life depression: an update
Willemijn Jansen · Mathieu Vandenbulcke
PET biomarkers of amyloid, tau, and synaptic density in geriatric depression, including the Leuven L3D study.
Dementia & Cognitive DisordersDepressionGeriatricNeuroscience & Mechanisms
- SymposiumMS02 – Proof-of-concept studies showcasing biomarker potential
Leanne Williams · Daniel Gehrlach
Stratified precision-medicine trials, including an alpha-2a agonist for the cognitive biotype of depression and phase 2 results for the vasopressin 1b antagonist nelivaptan.
DepressionPharmacogenomics & Precision PsychiatryDrug Pipeline & Clinical Trials
- LectureTP01 – Highlights in adult autism
Curated review of the year's most important papers on adult autism.
- LectureTP02 – Highlights in psychiatric genetics
Curated review of the year's top papers in psychiatric genetics.
- SessionPanel discussion – The innovation gap in mental health treatments – EU MIC
Andreas Reif · Concha Caudevilla Asensio · Åsa Konradsson-Geuken · Shaun Johnson
Panel on Europe's lag in psychiatric drug innovation, access delays, and paths to bring pharmaceutical innovation back.
- SessionRS – Regulatory Spotlight Session – Metabolic risks of psychiatric medications: improving clinical safety through regulatory, industry, and academic insights
Margaret Hahn · Vikas Mohan Sharma · Katarina Vucic
Academic, industry, and regulator perspectives on managing metabolic risks of psychotropic medications.
Antipsychotic PrescribingDrug Interactions & SafetyGLP-1 & Metabolic Psychiatry
October 12, 2026
- PlenaryPL03 – Brain Prize Lecture – Malignant networks in the brain
Brain Prize lecture on how cancers integrate into and exploit neural networks.
- SymposiumS10 – Innovative approaches to understanding and treating anxiety disorders: from neurobiology to cutting-edge therapies
Andre Pittig · Iiris Hovatta · David S. Baldwin · Peter Zwanzger
Fear extinction mechanisms, genetics, next-generation anxiolytics, and digital/VR therapies for anxiety disorders.
Anxiety DisordersDigital Psychiatry & AINeuroscience & Mechanisms
- SymposiumS11 – The impact of early-life stress on brain development and psychopathology
Juan Pablo Lopez · Thorhildur Halldorsdottir · Donghao Lu
Animal and cohort evidence on how early adversity and prenatal factors shape brain development and later psychopathology.
- SymposiumS12 – New Findings Symposium
A. Coen Coomans · Bengisu Aksoy · Maja Friedemann · Edoardo Pisa · Minh Nguyen · Laura Costantini
Six short talks on brand-new findings, from personalized rTMS targets in OCD to glymphatic function in depression and transcranial ultrasound stimulation.
- SymposiumS13 – The science of emotion regulation: integrating neuroscience, microbiome, and mindfulness
Carmen Morawetz · Ulrike Basten · Nils Kohn · Olga Klimecki
Inflammation & ImmunopsychiatryNeuroscience & MechanismsPsychotherapy
- SymposiumS14 – Dysregulation of perineuronal nets, astrocytes and extrasynaptic transmission in neurodegeneration and mental disorders
Juan Nacher · Eva Sykova · Jessica Kwok · Dominik Bach
Extracellular matrix and perineuronal net biology as levers for reactivating plasticity in brain disease.
- SymposiumS15 – Novel Therapies Symposium – showcasing clinical trials on emerging compounds and new medical devices
Lone Baandrup · Viktoria Damgaard · Daniel Umbricht · Susan L. Rossell · Alexandra Philipsen · Mikołaj Matłoka
Trial results on emerging treatments including cannabidiol vs risperidone for cannabis-related psychosis (CANRISE), a novel oral NMDA antagonist, PDE10A inhibition in schizophrenia, and digital devices.
Cannabis & CannabinoidsDrug Pipeline & Clinical TrialsSchizophrenia & Psychosis
- LectureE04 – Chronic pain in mental health disorders – what do we know and where are we going?
Composite pain biomarkers and the neurobiology linking chronic pain with psychiatric comorbidity.
Neuroscience & MechanismsMedical Comorbidity & C-L Psychiatry
- LectureE05 – Computational psychiatry: promises and pitfalls
Critical appraisal of computational modelling in psychiatry and its path to mechanism-based treatments.
- CourseCS01 - ECNP Neuromodulation Course Session – from mechanisms to clinical application
Roel Mocking · Iris Dalhuisen · Annemiek Dols · Victoria Stiglbauer
Interactive course working through difficult-to-treat OCD and depression cases with neuromodulation approaches.
Neuromodulation (ECT, TMS)OCD & Related DisordersTreatment-Resistant Depression
- CourseCS02 – ECNP Child & Adolescent Psychiatry Course Session – from evidence-based care to precision approaches
Hilgo Bruining · Gonzalo Salazar de Pablo
Interactive course on evidence-based and precision approaches to child and adolescent psychiatry and neurodevelopmental disorders.
Autism & Neurodevelopmental DisordersChild & AdolescentPharmacogenomics & Precision Psychiatry
- CourseCS03 – ECNP Neuroscience Research course session – from preclinical validity to real-world impact
Anton Y. Bespalov · Simone Macri · Janko Samardzic · Patricia Kabitzke
Course on internal and external validity of preclinical data and communicating neuropsychopharmacology to the public.
- SymposiumMS03 – DSM Update Session – Future DSM diagnostic formulation: the promise of integrating dimensionality, biomarkers and transdiagnostic symptoms
APA speakers discuss how dimensional measures, biomarkers, and transdiagnostic symptoms could reshape future DSM formulations.
- SymposiumMS04 – EAN Mini Symposium – Rethinking the psychiatric approach in neurology conditions: in case of movement disorders
Anna Rita Bentivoglio · Jaime Kulisevsky
Joint neurology session on psychiatric management in Huntington's disease and Parkinson's disease psychosis.
Tardive Dyskinesia & Movement DisordersSchizophrenia & PsychosisMedical Comorbidity & C-L Psychiatry
- SymposiumMS05 – The Earth-Brain-Health Commission: aims, recommendations and impact
Gunter Schumann · Cornelius Gross · Xanthe Hunt
Presents the commission's recommendations on environment-brain-health interactions and global implementation.
- LectureTP03 – Highlights in women's mental health
Curated review of the year's top papers in women's mental health.
- LectureTP04 – Highlights in suicide
Curated review of the year's top papers in suicide research.
October 13, 2026
- PlenaryPL05 – Advancing mental health in a changing world: social context and biology
Plenary integrating social determinants and biological research in global mental health, from an East African vantage point.
- PlenaryPL06 – Virtual reality in youth mental health: evidence, applications and future directions
Plenary reviewing the evidence for VR-based assessment and treatment in youth mental health.
- SymposiumS16 – Cutting edge neuromodulation methods in brain disorders: methods, mechanisms and personalised targeting
Yvan Vachez · Katya Rubia · Odile van den Heuvel · Christine Reif-Leonhard
DBS, trigeminal nerve stimulation in ADHD, rTMS-augmented exposure therapy for OCD, and implantable VNS for difficult-to-treat depression.
ADHDNeuromodulation (ECT, TMS)OCD & Related DisordersTreatment-Resistant Depression
- SymposiumS17 – Nature's shield: towards the neurobiology of resilience to psychiatric conditions
Eric Barnett · Joëlle Rüegg · Linda A. Antonucci · Daphne Holt
Genetic, environmental, and clinical approaches to identifying resilience factors against psychiatric illness.
- SymposiumS18 – Closing the translational gap in addiction research: refining animal models for clinical impact
Serge Ahmed · Kasia Radwanska · Steven Laviolette · Karen Ersche
How refined animal models of alcohol, nicotine, and cannabis use can better inform addiction treatment.
Alcohol Use DisorderNeuroscience & MechanismsSubstance Use Disorders
- SymposiumS19 – Bridging preclinical and clinical findings in psychedelic research – translational advances in psychedelic research
Tomas Palenicek · Luisa Pinto · Sophie Holmes · Annette Johansen
Psilocybin and ketamine effects on neurogenesis, synaptic plasticity, and the role of setting, from bench to PET imaging.
- SymposiumS20 – How can artificial intelligence transform mental health research?
Eleonora Maggioni · Pavol Mikolas · Saige Rutherford · Lin Baihan
Multimodal AI for patient stratification, generative AI for symptom extraction, and algorithmic fairness in clinical neuroscience.
Digital Psychiatry & AIPharmacogenomics & Precision Psychiatry
- SymposiumS21 – Neurobiology and clinical translation of treatment resistance in major psychiatric disorders
Michael Ziller · Esmée Verwijk · Alessandra Minelli · Koen Demyttenaere
iPSC models, pharmacogenomics, ECT cognitive effects, and lived-experience perspectives on treatment resistance.
Neuromodulation (ECT, TMS)Neuroscience & MechanismsPharmacogenomics & Precision PsychiatryTreatment-Resistant Depression
- SymposiumS22 – Excess mortality in people with mental health problems – influence of comorbidity
Elias Wagner · Ana Jiménez Peinado · Toby Pillinger · J. John Mann
Evidence on premature mortality in anxiety, bipolar disorder, and schizophrenia, and the role of physical comorbidity and inflammation.
Inflammation & ImmunopsychiatrySchizophrenia & PsychosisSerious Mental IllnessMedical Comorbidity & C-L Psychiatry
- LectureE06 – The arts and mental health
Ekin Sönmez Güngör · Christian Gold
Arts-based strategies and the translation of music therapy into clinical mental health practice.
- LectureE07 – Long-term effects of ADHD medication: new evidence from real-world data
Real-world evidence on long-term academic outcomes and the safety of methylphenidate in children.
- LectureTP05 – Highlights in obsessive-compulsive and related disorders
Curated review of the year's top papers in OCD and related disorders.
- LectureTP06 – Highlights in old age
Curated review of the year's top papers in old-age psychiatry.
- SessionPanel discussion – Artificial intelligence in mental health – Progress and perils
Paris Alexandros Lalousis · Raquel Iniesta · Joseph Kambeitz · Ioana R. Podina
The ECNP AI in Mental Health network presents its European implementation effort, followed by a panel on limitations and risks of current AI systems.
Never miss an early-bird deadline
One-click alerts for this conference — we email you 14 and 3 days before each deadline:
Browse the directory
By date
By specialty
- General Psychiatry
- Psychopharmacology
- Child & Adolescent Psychiatry
- Addiction Psychiatry
- Geriatric Psychiatry
- Forensic Psychiatry
- Consultation-Liaison Psychiatry
- Anxiety & Depression
- Neuroscience
- Psychiatric Nursing / PMHNP
- ADHD
- Bipolar Disorders
- Schizophrenia & Psychosis
- Trauma & PTSD
- Women's & Perinatal Mental Health
- Psychotherapy
- Emergency Psychiatry
- Interventional Psychiatry & Neuromodulation
- Psychedelic Medicine
- Suicide Prevention
- OCD & Related Disorders
- Autism Spectrum
- Sleep Medicine
By location
- International
- Midwest US
- Northeast US
- Southern US
- Western US
- California (6)
- Chicago (5)
- Illinois (5)
- San Diego (5)
- Colorado (4)
- Florida (4)
- Denver (3)
- Louisiana (3)
- New Orleans (3)
- New Zealand (3)
- Reston (3)
- Texas (3)
- Virginia (3)
- Austin (2)
- Australia (2)
- Hawaii (2)
- New York (2)
- Orlando (2)
- Washington (2)
- Washington, D.C. (2)
- Adelaide (1)
- Albuquerque (1)
- Arizona (1)
- Asheville (1)
- Atlanta (1)
- Auckland (1)
- Bahamas (1)
- Baltimore (1)
- Barcelona (1)
- Boston (1)
- Brazil (1)
- Canada (1)
- Cape Town (1)
- Cartagena (1)
- Christchurch (1)
- Cincinnati (1)
- Colombia (1)
- Colorado Springs (1)
- Dallas (1)
- Florence (1)
- France (1)
- Georgia (1)
- Glasgow (1)
- Italy (1)
- Kapolei (1)
- Kentucky (1)
- Koloa (Kauai) (1)
- Lake Buena Vista (1)
- Las Vegas (1)
- Louisville (1)
- Lyon (1)
- Maryland (1)
- Massachusetts (1)
- Minneapolis (1)
- Minnesota (1)
- Montreal (1)
- Nashville (1)
- Nevada (1)
- New Mexico (1)
- North Carolina (1)
- Ohio (1)
- Paradise Island (1)
- Queenstown (1)
- Rio de Janeiro (1)
- San Francisco (1)
- Scottsdale (1)
- South Africa (1)
- Spain (1)
- Tennessee (1)
- Thredbo Village (1)
- United Kingdom (1)
By type
By audience
Speakers & topics
Recurring meetings
- All conference series
- AAAP Annual Meeting and Scientific Symposium
- AACAP Annual Meeting
- AADPRT Annual Meeting
- AAGP Annual Meeting
- AAPL Annual Meeting
- AAPP Annual Meeting
- AAS Annual Conference
- ACLP Annual Meeting
- ACNP Annual Meeting
- ADAA Annual Conference
- AGPA Connect
- AMERSA Annual National Conference
- ANPA Annual Meeting
- APA Annual Meeting
- APNA Annual Conference
- APNA Clinical Psychopharmacology Institute
- APSARD Annual Conference
- APsA National Meeting
- ASAM Annual Conference
- ASCP Annual Meeting
- ASKP3 Annual Conference
- Annual International Conference on ADHD
- Annual OCD Conference
- Best Practices for Mood Disorders
- CINP World Congress of Neuropsychopharmacology
- Child & Adolescent Psychopharmacology (MGH Psychiatry Academy)
- ECNP Congress
- European Congress of Psychiatry
- IEPA International Conference on Early Intervention in Mental Health
- INSAR Annual Meeting
- ISBD Annual Conference
- ISPN Annual Conference
- ISTSS Annual Meeting
- International Brain Stimulation Conference
- International Marcé Society Biennial Conference
- MGH Annual Conference on Psychedelics and Psychedelic Medicine
- MGH Annual Psychopharmacology Conference
- MasterPsych Child & Adolescent Psychiatry Conference
- MasterPsych Psychiatry Conference
- Mayo Clinic Psychiatry Clinical Updates
- Medical Psychiatry: Comprehensive Update Conference
- NEI Congress
- NPA National Psychopharmacology Update
- NPACE Napa: Mental Health & Women's Health Conference
- National Update on Behavioral Emergencies (NUBE)
- Postpartum Support International Annual Conference
- Psych Congress
- Psych Congress NP Institute
- Psychedelic Science
- RANZCP Congress
- RCPsych International Congress
- SBSM Annual Meeting (formerly American Psychosomatic Society Annual Meeting)
- SIRS Congress
- SLEEP Annual Meeting (APSS)
- SOBP Annual Meeting
- Substance Use Disorders: A Comprehensive Review and Update
- WFSBP World Congress of Biological Psychiatry
- World Congress of Psychiatry